☰

Ziva D. Cooper, Ph.D. - Publications

Affiliations: 
2001-2007 Biopsychology University of Michigan, Ann Arbor, Ann Arbor, MI 
 2007- Psychiatry Columbia University College of Physicians and Surgeons, New York, NY, United States 
 2007- Psychiatry New York State Psychiatric Institute, New York, NY, United States 
Area:
behavioral pharmacology, opioids, cannabinoids, cannabis, pain, substance use
Tree Info Grants Similar researchers PubMed Report error

54 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Murray CH, Haney M, Foltin RW, Manubay J, Bedi G, Cooper ZD. Smoked cannabis reduces peak cocaine plasma levels and subjective effects in a controlled drug administration study of polysubstance use in men. Drug and Alcohol Dependence. 243: 109757. PMID 36608482 DOI: 10.1016/j.drugalcdep.2022.109757  0.328
2021 Lake S, Kerr T, Buxton J, Walsh Z, Cooper ZD, Socías ME, Fairbairn N, Hayashi K, Milloy MJ. The Cannabis-Dependent Relationship Between Methadone Treatment Dose and Illicit Opioid Use in a Community-Based Cohort of People Who Use Drugs. Cannabis and Cannabinoid Research. PMID 34813374 DOI: 10.1089/can.2021.0080  0.321
2019 Lake S, Walsh Z, Kerr T, Cooper ZD, Buxton J, Wood E, Ware MA, Milloy MJ. Frequency of cannabis and illicit opioid use among people who use drugs and report chronic pain: A longitudinal analysis. Plos Medicine. 16: e1002967. PMID 31743343 DOI: 10.1371/Journal.Pmed.1002967  0.373
2019 Cooper ZD, Abrams D. Considering abuse liability and neurocognitive effects of cannabis and cannabis-derived products when assessing analgesic efficacy: a comprehensive review of randomized-controlled studies. The American Journal of Drug and Alcohol Abuse. 1-16. PMID 31687845 DOI: 10.1080/00952990.2019.1669628  0.364
2019 Chao T, Haney M, Cooper ZD, Vadhan NP, Van Dam NT, Van Snellenberg J, Bedi G. Cognitive function in aging cocaine smokers. Journal of Psychopharmacology (Oxford, England). 269881119849812. PMID 31169441 DOI: 10.1177/0269881119849812  0.376
2018 Herrmann ES, Cooper ZD, Bedi G, Ramesh D, Reed SC, Comer SD, Foltin RW, Haney M. Varenicline and nabilone in tobacco and cannabis co-users: effects on tobacco abstinence, withdrawal and a laboratory model of cannabis relapse. Addiction Biology. PMID 30378231 DOI: 10.1111/Adb.12664  0.343
2018 Bedi G, Hao X, Van Dam NT, Cooper ZD, Rubin E, Vadhan NP, Marino L, Haney M. Social motivational processing and interpersonal function in aging cocaine smokers. Addiction Biology. PMID 30328665 DOI: 10.1111/Adb.12669  0.394
2018 Haney M, Cooper ZD, Bedi G, Herrmann E, Comer SD, Reed SC, Foltin RW, Levin FR. Guanfacine decreases symptoms of cannabis withdrawal in daily cannabis smokers. Addiction Biology. PMID 29659126 DOI: 10.1111/Adb.12621  0.381
2018 Cooper ZD, Bedi G, Ramesh D, Balter R, Comer SD, Haney M. Impact of co-administration of oxycodone and smoked cannabis on analgesia and abuse liability. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 29463913 DOI: 10.1038/S41386-018-0011-2  0.445
2018 Bedi G, Hao X, Van Dam N, Cooper Z, Vadhan N, Haney M. F259. Social Motivational Processing and Interpersonal Function in Aging Cocaine Smokers Biological Psychiatry. 83: S339-S340. DOI: 10.1016/J.Biopsych.2018.02.873  0.364
2017 Cooper ZD, Craft RM. Sex-Dependent Effects of Cannabis and Cannabinoids: A Translational Perspective. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 28811670 DOI: 10.1038/Npp.2017.140  0.314
2017 Cooper ZD, Johnson KW, Vosburg SK, Sullivan MA, Manubay J, Martinez D, Jones JD, Saccone PA, Comer SD. Effects of ibudilast on oxycodone-induced analgesia and subjective effects in opioid-dependent volunteers. Drug and Alcohol Dependence. 178: 340-347. PMID 28688296 DOI: 10.1016/J.Drugalcdep.2017.04.029  0.407
2017 Herrmann ES, Cooper Z, Bedi G, Ramesh D, Reed SC, Comer SD, Foltin R, Haney M. Effects of zolpidem alone and in combination with nabilone on cannabis withdrawal and relapse among non-treatment-seeking cannabis users Drug and Alcohol Dependence. 171: e88. DOI: 10.1016/J.Drugalcdep.2016.08.247  0.315
2017 Cooper ZD, Comer SD, Haney M. Opioid modulation of cannabis-induced analgesia and subjective effects in cannabis smokers Drug and Alcohol Dependence. 171: e44-e45. DOI: 10.1016/J.Drugalcdep.2016.08.135  0.391
2016 Cooper ZD, Haney M. Sex-dependent effects of cannabis-induced analgesia. Drug and Alcohol Dependence. PMID 27522535 DOI: 10.1016/J.Drugalcdep.2016.08.001  0.338
2016 Herrmann ES, Cooper ZD, Bedi G, Ramesh D, Reed SC, Comer SD, Foltin RW, Haney M. Effects of zolpidem alone and in combination with nabilone on cannabis withdrawal and a laboratory model of relapse in cannabis users. Psychopharmacology. PMID 27085870 DOI: 10.1007/S00213-016-4298-6  0.314
2016 Cooper ZD. Adverse Effects of Synthetic Cannabinoids: Management of Acute Toxicity and Withdrawal. Current Psychiatry Reports. 18: 52. PMID 27074934 DOI: 10.1007/S11920-016-0694-1  0.37
2015 Haney M, Malcolm RJ, Babalonis S, Nuzzo PA, Cooper ZD, Bedi G, Gray KM, McRae-Clark A, Lofwall MR, Sparenborg S, Walsh SL. Oral Cannabidiol does not Alter the Subjective, Reinforcing or Cardiovascular Effects of Smoked Cannabis. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 26708108 DOI: 10.1038/Npp.2015.367  0.413
2015 Cooper ZD, Johnson KW, Pavlicova M, Glass A, Vosburg SK, Sullivan MA, Manubay JM, Martinez DM, Jones JD, Saccone PA, Comer SD. The effects of ibudilast, a glial activation inhibitor, on opioid withdrawal symptoms in opioid-dependent volunteers. Addiction Biology. PMID 25975386 DOI: 10.1111/Adb.12261  0.419
2015 Haney M, Ramesh D, Glass A, Pavlicova M, Bedi G, Cooper ZD. Naltrexone Maintenance Decreases Cannabis Self-Administration and Subjective Effects in Daily Cannabis Smokers. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 25881117 DOI: 10.1038/Npp.2015.108  0.437
2015 Bedi G, Cooper ZD, Van Dam N, Haney M. Social processing in aging cocaine smokers Drug and Alcohol Dependence. 156: e17-e18. DOI: 10.1016/J.Drugalcdep.2015.07.966  0.384
2015 Cooper ZD, Haney M. Synthetic cannabinoid use in cannabis smokers Drug and Alcohol Dependence. 146: e250. DOI: 10.1016/J.Drugalcdep.2014.09.146  0.4
2014 Balter RE, Cooper ZD, Haney M. Novel Pharmacologic Approaches to Treating Cannabis Use Disorder. Current Addiction Reports. 1: 137-143. PMID 24955304 DOI: 10.1007/S40429-014-0011-1  0.327
2014 Cooper ZD, Haney M. Investigation of sex-dependent effects of cannabis in daily cannabis smokers. Drug and Alcohol Dependence. 136: 85-91. PMID 24440051 DOI: 10.1016/J.Drugalcdep.2013.12.013  0.331
2014 Sullivan M, Manubay J, Vosburg SK, Jones J, Cooper ZD, Fogel J, Davidson J, Comer SD. Buprenorphine/naloxone for the treatment of prescription opioid abuse and chronic pain Drug and Alcohol Dependence. 140: e220. DOI: 10.1016/J.Drugalcdep.2014.02.610  0.389
2014 Ramesh D, Haney M, Cooper ZD. Dose-dependent physiological and subjective effects of marijuana in daily marijuana smokers Drug and Alcohol Dependence. 140: e181-e182. DOI: 10.1016/J.Drugalcdep.2014.02.509  0.361
2014 Manubay JM, Davidson J, Vosburg S, Jones JD, Cooper ZD, Fogel J, Comer SD, Sullivan M. Sex differences among opioid-abusing chronic pain patients in a clinical trial Drug and Alcohol Dependence. 140: e133. DOI: 10.1016/J.Drugalcdep.2014.02.378  0.334
2013 Ramesh D, Haney M, Cooper ZD. Marijuana's dose-dependent effects in daily marijuana smokers. Experimental and Clinical Psychopharmacology. 21: 287-93. PMID 23937597 DOI: 10.1037/A0033661  0.371
2013 Comer SD, Metz VE, Cooper ZD, Kowalczyk WJ, Jones JD, Sullivan MA, Manubay JM, Vosburg SK, Smith ME, Peyser D, Saccone PA. Comparison of a drug versus money and drug versus drug self-administration choice procedure with oxycodone and morphine in opioid addicts. Behavioural Pharmacology. 24: 504-16. PMID 23839029 DOI: 10.1097/Fbp.0B013E328363D1C4  0.382
2013 Comer SD, Mogali S, Saccone PA, Askalsky P, Martinez D, Walker EA, Jones JD, Vosburg SK, Cooper ZD, Roux P, Sullivan MA, Manubay JM, Rubin E, Pines A, Berkower EL, et al. Effects of acute oral naltrexone on the subjective and physiological effects of oral D-amphetamine and smoked cocaine in cocaine abusers. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 38: 2427-38. PMID 23736314 DOI: 10.1038/Npp.2013.143  0.641
2013 Roux P, Sullivan MA, Cohen J, Fugon L, Jones JD, Vosburg SK, Cooper ZD, Manubay JM, Mogali S, Comer SD. Buprenorphine/naloxone as a promising therapeutic option for opioid abusing patients with chronic pain: reduction of pain, opioid withdrawal symptoms, and abuse liability of oral oxycodone. Pain. 154: 1442-8. PMID 23707283 DOI: 10.1016/J.Pain.2013.05.004  0.407
2013 Cooper ZD, Comer SD, Haney M. Comparison of the analgesic effects of dronabinol and smoked marijuana in daily marijuana smokers. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 38: 1984-92. PMID 23609132 DOI: 10.1038/Npp.2013.97  0.335
2013 Haney M, Cooper ZD, Bedi G, Vosburg SK, Comer SD, Foltin RW. Nabilone decreases marijuana withdrawal and a laboratory measure of marijuana relapse. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 38: 1557-65. PMID 23443718 DOI: 10.1038/Npp.2013.54  0.403
2013 Cooper ZD, Foltin RW, Evans SM. Effects of menstrual cycle phase on cocaine self-administration in rhesus macaques. Hormones and Behavior. 63: 105-13. PMID 23098805 DOI: 10.1016/J.Yhbeh.2012.10.008  0.439
2013 Cooper ZD, Foltin RW, Hart CL, Vosburg SK, Comer SD, Haney M. A human laboratory study investigating the effects of quetiapine on marijuana withdrawal and relapse in daily marijuana smokers. Addiction Biology. 18: 993-1002. PMID 22741619 DOI: 10.1111/J.1369-1600.2012.00461.X  0.384
2013 Bedi G, Cooper ZD, Haney M. Subjective, cognitive and cardiovascular dose-effect profile of nabilone and dronabinol in marijuana smokers. Addiction Biology. 18: 872-81. PMID 22260337 DOI: 10.1111/J.1369-1600.2011.00427.X  0.404
2012 Cooper ZD, Sullivan MA, Vosburg SK, Manubay JM, Haney M, Foltin RW, Evans SM, Kowalczyk WJ, Saccone PA, Comer SD. Effects of repeated oxycodone administration on its analgesic and subjective effects in normal, healthy volunteers. Behavioural Pharmacology. 23: 271-9. PMID 22495183 DOI: 10.1097/Fbp.0B013E3283536D6F  0.41
2012 Cooper ZD, Jones JD, Comer SD. Glial modulators: a novel pharmacological approach to altering the behavioral effects of abused substances. Expert Opinion On Investigational Drugs. 21: 169-78. PMID 22233449 DOI: 10.1517/13543784.2012.651123  0.35
2012 Roux P, Tindall C, Fugon L, Murray J, Vosburg SK, Saccone P, Sullivan MA, Manubay JM, Cooper ZD, Jones JD, Foltin RW, Comer SD. Impact of in-patient research participation on subsequent heroin use patterns: implications for ethics and public health. Addiction (Abingdon, England). 107: 642-9. PMID 21939462 DOI: 10.1111/J.1360-0443.2011.03664.X  0.356
2011 Gooch CM, Rakitin BC, Cooper ZD, Comer SD, Balsam PD. Oxycodone lengthens reproductions of suprasecond time intervals in human research volunteers. Behavioural Pharmacology. 22: 354-61. PMID 21750426 DOI: 10.1097/Fbp.0B013E328348D8B8  0.384
2010 Cooper ZD, Shi YG, Woods JH. Reinforcer-dependent enhancement of operant responding in opioid-withdrawn rats. Psychopharmacology. 212: 369-78. PMID 20686752 DOI: 10.1007/S00213-010-1966-9  0.585
2010 Haney M, Hart CL, Vosburg SK, Comer SD, Reed SC, Cooper ZD, Foltin RW. Effects of baclofen and mirtazapine on a laboratory model of marijuana withdrawal and relapse. Psychopharmacology. 211: 233-44. PMID 20521030 DOI: 10.1007/S00213-010-1888-6  0.392
2010 Cooper ZD, Haney M. Opioid antagonism enhances marijuana's effects in heavy marijuana smokers. Psychopharmacology. 211: 141-8. PMID 20490465 DOI: 10.1007/S00213-010-1875-Y  0.429
2010 Comer SD, Sullivan MA, Vosburg SK, Manubay J, Amass L, Cooper ZD, Saccone P, Kleber HD. Abuse liability of intravenous buprenorphine/naloxone and buprenorphine alone in buprenorphine-maintained intravenous heroin abusers. Addiction (Abingdon, England). 105: 709-18. PMID 20403021 DOI: 10.1111/J.1360-0443.2009.02843.X  0.443
2010 Comer SD, Cooper ZD, Kowalczyk WJ, Sullivan MA, Evans SM, Bisaga AM, Vosburg SK. Evaluation of potential sex differences in the subjective and analgesic effects of morphine in normal, healthy volunteers. Psychopharmacology. 208: 45-55. PMID 19859698 DOI: 10.1007/S00213-009-1703-4  0.381
2010 Wood SK, Narasimhan D, Cooper Z, Sunahara RK, Woods JH. Prevention and reversal by cocaine esterase of cocaine-induced cardiovascular effects in rats. Drug and Alcohol Dependence. 106: 219-29. PMID 19800183 DOI: 10.1016/J.Drugalcdep.2009.09.001  0.685
2010 Jutkiewicz EM, Baladi MG, Cooper ZD, Woods JH. In reply Annals of Emergency Medicine. 55: 485-486. DOI: 10.1016/j.annemergmed.2009.11.028  0.566
2009 Cooper ZD, Haney M. Actions of delta-9-tetrahydrocannabinol in cannabis: relation to use, abuse, dependence. International Review of Psychiatry (Abingdon, England). 21: 104-12. PMID 19367504 DOI: 10.1080/09540260902782752  0.381
2009 Jutkiewicz EM, Baladi MG, Cooper ZD, Narasimhan D, Sunahara RK, Woods JH. A bacterial cocaine esterase protects against cocaine-induced epileptogenic activity and lethality. Annals of Emergency Medicine. 54: 409-20. PMID 19013687 DOI: 10.1016/J.Annemergmed.2008.09.023  0.691
2008 Cooper ZD, Truong YN, Shi YG, Woods JH. Morphine deprivation increases self-administration of the fast- and short-acting mu-opioid receptor agonist remifentanil in the rat. The Journal of Pharmacology and Experimental Therapeutics. 326: 920-9. PMID 18515643 DOI: 10.1124/Jpet.108.139196  0.568
2008 Cooper ZD, Haney M. Cannabis reinforcement and dependence: role of the cannabinoid CB1 receptor. Addiction Biology. 13: 188-95. PMID 18279497 DOI: 10.1111/J.1369-1600.2007.00095.X  0.362
2007 Ko MC, Bowen LD, Narasimhan D, Berlin AA, Lukacs NW, Sunahara RK, Cooper ZD, Woods JH. Cocaine esterase: interactions with cocaine and immune responses in mice. The Journal of Pharmacology and Experimental Therapeutics. 320: 926-33. PMID 17114567 DOI: 10.1124/Jpet.106.114223  0.59
2006 Cooper ZD, Narasimhan D, Sunahara RK, Mierzejewski P, Jutkiewicz EM, Larsen NA, Wilson IA, Landry DW, Woods JH. Rapid and robust protection against cocaine-induced lethality in rats by the bacterial cocaine esterase. Molecular Pharmacology. 70: 1885-91. PMID 16968810 DOI: 10.1124/Mol.106.025999  0.696
2001 Houshyar H, Cooper ZD, Woods JH. Paradoxical effects of chronic morphine treatment on the temperature and pituitary-adrenal responses to acute restraint stress: a chronic stress paradigm. Journal of Neuroendocrinology. 13: 862-74. PMID 11679055 DOI: 10.1046/J.1365-2826.2001.00713.X  0.69
Show low-probability matches.